MMCAP International’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.7M Hold
350,000
0.32% 79
2025
Q4
$3.67M Hold
350,000
0.37% 66
2025
Q3
$3.62M Buy
+350,000
New +$3.61M 0.42% 54

Other funds holding TDAC

MMCAP International's TDAC Position: Q1 2026 in Review

MMCAP International held its Translational Development Acquisition Corp (TDAC) position steady in Q1 2026 at 350,000 shares worth $3.7M. The position accounts for 0.32% of the portfolio, ranked #79.

MMCAP International first reported a position in TDAC in Q3 2025 and has held it in 3 quarters since. 48 funds tracked by Wall St. Rank hold TDAC as of Q1 2026.

  • MMCAP International held 350,000 shares of Translational Development Acquisition Corp worth $3.7M as of Q1 2026.
  • MMCAP International left its Translational Development Acquisition Corp share count unchanged in Q1 2026.
  • Translational Development Acquisition Corp made up 0.32% of MMCAP International's portfolio in Q1 2026, its #79 holding.
  • MMCAP International first reported a position in Translational Development Acquisition Corp in Q3 2025 and has held it in 3 quarters since.
  • 48 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q1 2026.

Based on MMCAP International's 13F filing for Q1 2026, filed 15 May 2026.